{"organizations": [], "uuid": "d566bd557f94f4141768c0f58312e54c8b49dfc7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "http://si.wsj.net/public/resources/images/BN-KX733_VALEAN_G_20151025151957.jpg", "site_section": "http://www.wsj.com/news/business", "section_title": "Business &amp; Finance News - Wall Street Journal", "url": "http://www.wsj.com/articles/the-valeant-call-what-it-needs-to-address-1445801493", "country": "", "title": "The Valeant Call: What It Needs to Address", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "The Valeant Call: What It Needs to Address - WSJ", "spam_score": 0.0, "site_type": "news", "published": "2015-10-25T22:31:00.000+02:00", "replies_count": 0, "uuid": "d566bd557f94f4141768c0f58312e54c8b49dfc7"}, "author": "Charley Grant", "url": "http://www.wsj.com/articles/the-valeant-call-what-it-needs-to-address-1445801493", "ord_in_thread": 0, "title": "The Valeant Call: What It Needs to Address", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Valeant Pharmaceuticals International is hosting an investor call Monday morning at 8 a.m. as the company aims to refute what it calls “unsupported speculation and incorrect interpretations of facts and circumstances to the detriment of the shareholders” surrounding Valeant’s relationship with specialty pharmacies. Given Valeant’s stock fell about 35% last week on the back of investors fears over just this, the company has its work cut out... ", "external_links": [], "published": "2015-10-25T22:31:00.000+02:00", "crawled": "2015-10-25T21:48:09.333+02:00", "highlightTitle": ""}